Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.59 |
| ▸ | CTSB | P07858 | 3/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7202436 | 1.00 | CAPN1 (0.59) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL27559117 | 1.00 | CAPN1 (0.59) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL16488740 | 0.95 | CAPN1 (0.65) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL18626009 | 0.95 | CAPN1 (0.65) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL14673120 | 0.95 | CAPN1 (0.65) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL14673121 | 0.95 | CAPN1 (0.65) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL14682286 | 0.89 | CAPN1 (0.58) | CAPN1CTSBXIAPOPRM1ELANE | |
| SCHEMBL16994620 | 0.89 | CAPN1 (0.58) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL14728356 | 0.89 | CAPN1 (0.58) | CAPN1CTSBXIAPOPRM1SLC6A2 | |
| SCHEMBL28478644 | 0.88 | CAPN1 (0.53) | CAPN1CTSBXIAPOPRM1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030050242-A1 | Protein polymerization inhibitors and methods of use | TRIPEP AB (SE) | 2003-03-13 | — | — | US | disclosed |
| US-20020091086-A1 | Peptides that block viral infectivity and methods of use thereof | VAHLNE ANDERS (SE) | 2002-07-11 | — | — | US | disclosed |
| EP-1207897-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING TRIPEPTIDES | TRIPEP AB (SE) | 2002-05-29 | — | — | EP | disclosed |
| US-6258932-B1 | TRIPEPTIDE OF DEFINED AMINO ACID SEQUENCE AND HAVING A C-TERMINAL AMIDE; VIRICIDES; TREATMENT AND PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS | TRIPEP AB (BE) | 2001-07-10 | — | — | US | disclosed |
| WO-2001010457-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING TRIPEPTIDES | TRIPEP AB (SE) | 2001-02-15 | — | — | WO | disclosed |